Children for whom the differential diagnosis includes bipolar disorder and/or attention deficit hyperactivity disorder (ADHD; combined type) are usually complex and present thorny assessment and treatment problems. The cases of “Seth” and “Eric” illustrate these issues. They are presented in tandem to illustrate how information might unfold and how the flow of information directs treatment in situations where the question of bipolar disorder and/or ADHD is raised.
Background Information on Seth
Background Information on Eric
The Clinical Problem
Seth and Eric highlight the “bipolar disorder versus ADHD” or “bipolar disorder and ADHD” controversy in preadolescent children. They both had symptoms of ADHD, but they also had symptoms of severe mood lability, inadequate response to ADHD treatment (or any other medication for that matter), and family histories of mood disorders. Youngstrom et al. (1) attribute some of the bipolar/ADHD controversy to researchers’ use of different conceptualizations of bipolar disorder, different diagnostic interviews, and different criteria to define study samples. They also note that researchers’ definitions may alter the DSM-IV criteria and do not necessarily reflect how the diagnosis is used in clinical practice.
The question of the prevalence, pathophysiology, and treatment of bipolar disorder in children (versus adolescents) will obviously depend on how one diagnoses it. Literature review is unhelpful since most authors combine child and adolescent data or data on bipolar I disorder, bipolar II disorder, and bipolar disorder not otherwise specified. Whether research groups have used more liberal or more conservative definitions of episodes, euphoria, and grandiosity, they can marshal data to validate their approach.
Besides the question of how broadly or narrowly to define mania in youths, there is the related question of how to diagnose children with explosive, aggressive behavior. Previously these symptoms in children were included within the broad definition of hyperkinesis, the predecessor of ADHD. Laufer and Denhoff (2) described “behavior of almost volcanic intensity” and changeability such that the child could be “sometimes good and sometimes bad.” In DSM-III, this emotion component of hyperkinesis was split off from the “core” attention and hyperactivity symptoms, and the explosive, aggressive behaviors were absorbed into the “associated symptoms” of ADHD, oppositional disorder/oppositional defiant disorder, and conduct disorder. Investigators of aggression have developed their own terms—“affective,” “impulsive,” or “hot” aggression—which appear to identify the explosive behavior manifested by children usually with symptoms of ADHD (3) . Leibenluft et al. (4), exploring differences between children with episodic mania and those with chronic explosive behavior, called the latter “severe mood dysregulation.” This is distinguished from mania by the absence of episodes, euphoria, and grandiosity and the presence of prominent and chronic (at least 1 year) anger/irritability or sadness, with severe tantrums occurring several times a week in multiple settings. Other symptoms that may be seen in both mania and ADHD—insomnia, distractibility, flight of ideas, pressured speech, and intrusiveness—are also present. More than 80% of these children have comorbid ADHD and oppositional defiant disorder (5) .
Although debate rages about whether severe ADHD symptoms, fluctuating behavior, and short temper with significant aggression represent a virulent form of ADHD or a juvenile subtype of bipolar disorder, there is an evidence base, albeit a small one, for treating both conceptualizations—that is, mania with or without ADHD as well as ADHD with explosive aggression. Thus, practice parameters (6) and consensus documents (7) suggest that in bipolar disorder mood and/or mania should be treated first, and if ADHD symptoms remain, they should be addressed with evidence-based treatments for ADHD. Most of the data for effective treatments for mania in children (down to age 10) and adolescents come from FDA-requested, industry-sponsored studies of medications approved for mania in adults. Data have been published or presented demonstrating that for acute or mixed mania, about 50% of the patients treated with olanzapine, risperidone, quetiapine, or aripiprazole improve about 50%, compared with a response of about 25% with placebo (8, 9) . Results for divalproex are mixed (10, 11), and results for other mood stabilizers (e.g., oxcarbazepine) are disappointingly negative (12) . A large-scale placebo-controlled study of lithium is under way, but at this time the only similar study that has been conducted on acute mania in children and adolescents with lithium was negative (13) .
Treatment for ADHD includes stimulant medications or atomoxetine, behavior modification, and academic accommodations if needed (14) ; data also suggest that in cases where ADHD is accompanied by extreme aggression in the absence of a mood disorder, stimulants are somewhat beneficial (15 – 17) . There is, in fact, a mandate to begin controlled studies of children whose aggression is not satisfactorily addressed by ADHD treatments alone (3) .
There have been three small but systematic studies indicating that the addition of ADHD medications to antimanic medications in children with bipolar disorder and ADHD does not worsen symptoms and may improve them (18 – 20) . There have been no studies of atomoxetine in comorbid ADHD and bipolar disorder.
Circumstantial evidence indicates that even for children with manic-like symptoms, stimulants alone generally do not cause children to develop bipolar disorder (21 – 23), and where there is evidence of poor response or worsening of symptoms, the implications are nonspecific in that such responses may occur in any number of conditions (24 – 26) . There are anecdotal reports of atomoxetine-induced mania in children with ADHD, but to date, placebo-controlled trials of children with ADHD and depression have not provided evidence of a placebo-drug difference (27) . The phenomenon of switching and drug-induced disinhibition is difficult to study (28), and nonstimulant treatment of ADHD needs such attention.
Finally, evidence suggests that atypical antipsychotics, lithium, stimulants, and valproate are effective for treating aggression (29) . The ADHD practice parameter thus recommends the addition of these medications to ADHD treatments for patients who have ADHD plus aggression (14) .
Applied Assessment and Treatment
Diagnosis Expectations
Until we truly understand early-onset bipolar disorder, it will be important to acknowledge the different viewpoints about the condition and to determine both what parents’ understanding is and why they want to know whether the diagnosis pertains to their child. For instance, Seth’s mother had been told that his rages had prompted the bipolar disorder diagnosis. She had not described manic episodes—that is, distinct periods when Seth’s mood was clearly different from usual, lasting at least several days with concurrent elation/irritability, grandiosity, and accelerated verbal and physical activity. Rather, she noted that he became incredibly enraged for up to an hour when he did not get his way, was disappointed, or felt insulted. Some investigators (30) would concur that this presentation is likely bipolar disorder; others (4) would not diagnose bipolar disorder in the absence of discrete manic episodes. Seth’s mother wanted to know if he really had bipolar disorder in order to “find the right medication.”
Eric’s bipolar disorder diagnosis was made by his referring clinician after the apparent worsening of his symptoms on stimulant medication, and it was additionally supported by his positive family history. Unlike with Seth, in Eric’s case there appeared to be a distinct period, after he began treatment with a stimulant, in which his mood was markedly worse than usual, although it was not clear whether this period met other DSM-IV criteria for a manic episode. Regardless, some investigators view increased irritability on stimulants and other medications as evidence of a manic switch, which is especially portentous in the context of a family history of bipolar disorder (31) . Unlike Seth’s mother, Eric’s parents wanted to know their son’s trajectory. Current treatment was also important, but the long-term implications concerned them more.
Comprehensive Assessment
Comprehensive, standardized parent and teacher rating scales are an important preliminary part of an ADHD evaluation (14) . Screening measures have likewise been advocated for bipolar disorder (6) . The best screens cover the important comorbidities and “rule-outs,” including ADHD, oppositional defiant disorder, conduct disorder, anxiety and depressive disorders, psychosis, tic disorders, autism, and, of course, mania. These measures do not make a diagnosis but, accurately completed, alert the clinician to important problem areas to be pursued further.
Seth’s ratings showed parent and teacher concordance for high levels of hyperactivity, impulsivity and distractibility, oppositional defiance, conduct disorder, generalized anxiety, and deviant language items (rapid, excessive, off-topic speech). There were differences in mania ratings on the Child Mania Rating Scale (32), however. A parent score of 16 was made up of items reflecting irritability, explosive behavior, distractibility, and rapid speech. (Often it is helpful to know not only a score but what items were rated to achieve the score.) The teacher score was 24, reflecting, in addition to irritability and explosiveness, periods when Seth was “wound up and excited” or had higher than usual energy. Like Jensen et al. (33), we find that the reasons ratings are discordant, in this case between parent and teacher, are as informative as specific scores. For instance, Seth was explosive both at home and at school, but his teacher noted additional symptoms. We need to know why there is a discrepancy between his mother’s and his teacher’s ratings.
Seth’s school report underscored a notable disability in math and written expression, which had been present since first grade. He had a full-scale IQ of 84, with especially poor performance in working memory and processing speed.
Eric’s ratings evidenced different inconsistencies between parents and teachers. His parents noted manic and depressive symptoms in addition to severe ADHD and oppositional defiant behavior, whereas his teachers endorsed only ADHD and oppositional defiance. Eric, previously at grade level, experienced a drop in grades over the past several years. It will be important to try to understand why.
Parent and Child Interview
Although interviews developed for the study of mood disorders in children have good reliability, what is rarely discussed is the fact that reporting on one’s own behavior may pose a difficult cognitive task, and both parent and child reports can be profoundly influenced by question wording, format, and context (34) .
Seth’s Mood Disorder History and Mental Status
Eric’s Mood Disorder History and Mental Status
Treatment and Discussion
Seth’s Treatment and Follow-Up
Eric’s Treatment and Follow-Up
Conclusion
There are important reasons why mania and severe ADHD should be understood as different conditions. However, from a therapeutic standpoint, the difference between mania and severe ADHD (plus aggression) is not in the use of atypical antipsychotics and mood stabilizers, both of which are supported by a substantial evidence base for use in both disorders. Nor is it in the need to provide psychoeducation and specific parenting help for families. There is a robust literature on behavioral treatment for ADHD and a growing literature on psychosocial treatments for bipolar disorder (39) . Although the terms used to describe interventions to control dysregulated mood and aggressive behavior are different, many of the actual interventions are similar. Two of the most substantial differences in treatment are whether or when to treat ADHD and how to advise parents and child about future treatment.
As we have seen, both Seth and Eric had a long history of ADHD, a volatile temper, and problems with mood regulation, overwhelming parents and teachers alike. Both were significantly challenged academically and had more than ADHD. The diagnosis of bipolar disorder rests on demonstrating an episode, a sustained period of behavior that differs from the person’s usual self, in which elated/expansive/irritable mood co-occurs with other symptoms that operationalize the accelerated energy, thinking, and hyperhedonic activity that underpin mania. Seth was actually observed to have such a period lasting several weeks during which he appeared different—that is, excessively elated, even more explosive than previously, grandiose, and “constructively” energetic (in contrast to his background hyperactivity), with changes in sleep behavior. Once these features were pointed out, his teachers and his mother confirmed that they had occurred previously.
A case might be made that Eric also had an episode, starting around third grade, when his behavior worsened. His aggression and frustration intolerance increased, but he did not experience a simultaneous co-occurrence of other manic symptoms. His ADHD was inadequately treated, but his psychiatrist, concerned about his family history of bipolar disorder, chose to initiate treatment for that disorder.
Both Seth and Eric, even when treated with the best medication and parent and school interventions, remained somewhat symptomatic, which illustrates the fact that we simply do not yet have completely effective treatments for many children with this constellation of symptoms and behaviors.
In diagnosing bipolar disorder in children, it is necessary to keep an open mind, and to continue to do so after the first interview; ongoing observation is critical. A family history of bipolar disorder is important but does not, in and of itself, make a diagnosis. A full assessment, using multiple informants, is needed to address differential diagnosis, including learning and language disorders. Ultimately, it is important to understand the child, not just to reach a diagnosis.
Footnote
Received July 30, 2008; revision received Sept. 14, 2008; accepted Sept. 22, 2008 (doi: 10.1176/appi.ajp.2008.08091362). From the Division of Child and Adolescent Psychiatry, Stony Brook University School of Medicine. Address correspondence and reprint requests to Dr. Carlson, Director, Division of Child and Adolescent Psychiatry, Stony Brook University School of Medicine, Putnam Hall-South Campus, Stony Brook, NY 11794-8790; [email protected] (e-mail).Dr. Carlson has received research funding from Bristol-Myers Squibb, GlaxoSmithKline, Eli Lilly, NIMH, and Otsuka and has consulted for Eli Lilly and Otsuka.
References
1.
Youngstrom E, Meyers O, Youngstrom JK, Calabrese JR, Findling RL: Diagnostic and measurement issues in the assessment of pediatric bipolar disorder: implications for understanding mood disorder across the life cycle. Dev Psychopathol 2006; 18:989–1021
McClellan J, Kowatch R, Findling RL, Work Group on Quality Issues: Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2007; 46:107–125
Kowatch RA, Fristad M, Birmaher B, Wagner KD, Findling RL, Hellander M, Child Psychiatric Workgroup on Bipolar Disorder: Treatment guidelines for children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2005; 44:213–235
Carlson GA, Meyer SE: Bipolar disorder in children and adolescents, in Textbook of Child and Adolescent Psychiatry. Edited by Dulcan M. Arlington, Va, American Psychiatric Press, Inc (in press)
Wagner KD, Kowatch RA, Emslie GJ, Findling RL, Wilens TE, McCague K, D’Souza J, Wamil A, Lehman RB, Berv D, Linden D: A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. Am J Psychiatry 2006; 163:1179–1186
Kowatch RA, Scheffer R, Findling RL: Placebo controlled trial of divalproex versus lithium for bipolar disorder, in 2007 Proceedings of the American Academy of Child and Adolescent Psychiatry Annual Meeting. Washington, DC, American Academy of Child and Adolescent Psychiatry, 2007
Pliszka S, AACAP Work Group on Quality Issues: Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2007; 46:894–921
Sinzig J, Döpfner M, Lehmkuhl G; German Methylphenidate Study Group, Uebel H, Schmeck K, Poustka F, Gerber WD, Günter M, Knölker U, Gehrke M, Hässler F, Resch F, Brünger M, Ose C, Fischer R: Long-acting methylphenidate has an effect on aggressive behavior in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2007; 17:421–432
Klein RG, Abikoff H, Klass E, Ganeles D, Seese LM, Pollack S: Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder. Arch Gen Psychiatry 1997; 54:1073–1080
Waxmonsky J, Pelham W, Cummings M, O’Connor B, Majumdar A, Verley J, Hoffman M, Massetti G, Burrows-MacLean L, Fabiano G, Chacko A, Arnold F, Walker K, Garefino A, Robb J: The impact of manic-like symptoms on the multimodal treatment of pediatric attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol (in press)
Carlson GA, Rapport MD, Kelly KL, Pataki CS: The effects of methylphenidate and lithium on attention and activity level. J Am Acad Child Adolesc Psychiatry 1992; 31:262–270
Scheffer RE, Kowatch RA, Carmody T, Rush AJ: Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. Am J Psychiatry 2005; 162:58–64
Findling RL, Short EJ, McNamara NK, Demeter CA, Stansbrey RJ, Gracious BL, Whipkey R, Manos MJ, Calabrese JR: Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2007; 46:1445–1453
Carlson GA, Loney J, Salisbury H, Kramer JR, Arthur C: Stimulant treatment in young boys with symptoms suggesting childhood mania: a report from a longitudinal study. J Child Adolesc Psychopharmacol 2000; 10:175–184
Galanter CA, Carlson GA, Jensen PS, Greenhill LL, Davies M, Li W, Chuang SZ, Elliott GR, Arnold LE, March JS, Hechtman L, Pelham WE, Swanson JM: Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the Multimodal Treatment Study of Children With Attention Deficit Hyperactivity Disorder titration trial. J Child Adolesc Psychopharmacol 2003; 13:123–136
Pagano ME, Demeter CA, Faber JE, Calabrese JR, Findling RL: Initiation of stimulant and antidepressant medication and clinical presentation in juvenile bipolar I disorder. Bipolar Disord 2008; 10:334–341
Tillman R, Geller B: Controlled study of switching from attention-deficit/hyperactivity disorder to a prepubertal and early adolescent bipolar I disorder phenotype during 6-year prospective follow-up: rate, risk, and predictors. Dev Psychopathol 2006; 18:1037–1053
Mick E, Spencer T, Wozniak J, Biederman J: Heterogeneity of irritability in attention-deficit/hyperactivity disorder subjects with and without mood disorders. Biol Psychiatry 2005; 58:576–582
DelBello MP, Soutullo CA, Hendricks W, Niemeier RT, McElroy SL, Strakowski SM: Prior stimulant treatment in adolescents with bipolar disorder: association with age at onset. Bipolar Disord 2001; 3:53–57
Purvis KL, Tannock R: Language abilities in children with attention deficit hyperactivity disorder, reading disabilities, and normal controls. J Abnorm Child Psychol 1997; 25:133–144
Burke JD, Pardini DA, Loeber R: Reciprocal relationships between parenting behavior and disruptive psychopathology from childhood through adolescence. J Abnorm Child Psychol 2008; 36:679–692
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
If the address matches an existing account you will receive an email with instructions to retrieve your username
Create a new account
Change Password
Password Changed Successfully
Your password has been changed
Login
Reset password
Can't sign in? Forgot your password?
Enter your email address below and we will send you the reset instructions
If the address matches an existing account you will receive an email with instructions to reset your password.
Change Password
Congrats!
Your Phone has been verified
×
As described within the American Psychiatric Association (APA)'s Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences. Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.